Phase I Study of Fecal Microbial Transplants in Patients with Pancreatic Cancer
The purpose of this early phase I trial is to evaluate the safety and efficacy of fecal microbial transplants in patients with resectable pancreatic cancer.
Study ID: 2020-0788
Trial Phase: Phase I
Trial Sponsor: M.D. Anderson Cancer Center
Therapies Used in This Trial: Fecal Microbiota Transplantation Capsule